Targeting endothelial cells with heme oxygenase-1 gene using VE-cadherin promoter attenuates hyperglycemia-mediated cell injury and apoptosis

Antioxidants and Redox Signaling

Volumn 9, Issue 12, 2007, Pages 2065-2074

  Asija, Amit ^a   Peterson, Stephen J ^a   Stec, David E ^b   Abraham, Nader G ^a,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; HEME OXYGENASE 1; PROTEIN BCL XL; PROTEIN KINASE B; SUPEROXIDE; TUMOR NECROSIS FACTOR; VASCULAR ENDOTHELIAL CADHERIN;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE CONSTRUCT; GENE TARGETING; HUMAN; HUMAN CELL; HYPERGLYCEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ANTIGENS, CD; APOPTOSIS; CADHERINS; CAPILLARIES; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; COMET ASSAY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUCOSE; HEME OXYGENASE-1; HUMANS; HYPERGLYCEMIA; KIDNEY; MUSCLE, SMOOTH; PLASMIDS; PROMOTER REGIONS (GENETICS); SKIN; TUMOR NECROSIS FACTOR-ALPHA;

ADENOVIRIDAE;

EID: 35848955430     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1804     Document Type: Article

References (59)

1. Abraham NG and Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 39: 1-25, 2005.
2. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, and Wolin M. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93: 507-514, 2003.
3. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li VG, Goodman AI, and Kappas A. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287: H2468-H2477, 2004.
4. Anderson RD, Haskell RE, Xia H, Roessler BJ, and Davidson BL. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 7: 1034-1038, 2000.
5. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, and Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44: 1323-1327, 1995.
6. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Soares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
7. Deramaudt TB, daSilva JL, Remy P, Kappas A, and Abraham NG. Negative regulation of human heme oxygenase in microvessel endothelial cells by dexamethasone. Proc Soc Exp Biol Med 222: 185-193, 1999.
8. Di Noia MA, Van DS, Palmieri F, Yang LM, Quan S, Goodman AI, and Abraham NG. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J Biol Chem 281: 15687-15693, 2006.
9. Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, and Remppis A. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc Diabetol 5: 6, 2006.
10. Endemann DH and Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 15: 1983-1992, 2004.
11. Fujio Y, Nguyen T, Wencker D, Kitsis RN, and Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667, 2000.
12. Fujioka M, Okuchi K, Sakaki T, Hiramatsu K, Miyamoto S, and Iwasaki S. Specific changes in human brain following reperfusion after cardiac arrest. Stroke 25: 2091-2095, 1994.
13. Gory S, Dalmon J, Prandini MH, Kortulewski T, de LY, and Huber P. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J Biol Chem 273: 6750-6755, 1998.
14. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
15. Haugen EN, Croatt AJ, and Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58: 144-152, 2000.
16. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, and Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85: 663-671, 1999.
17. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001.
18. Ii M, Takenaka H, Asai J, Ibusuki K, Mizukami Y, Maruyama K, Yoon YS, Wecker A, Luedemann C, Eaton E, Silver M, Thorne T, and Losordo DW. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res 98: 697-704, 2006.
19. Ishikawa K, Navab M, Leitinger N, Fogelman AM, and Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209-1216, 1997.
20. Kalogeris TJ, Kevil CG, Laroux FS, Coe LL, Phifer TJ, and Alexander JS. Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. Am J Physiol 276: L9-L19, 1999.
21. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 20: 443-448, 1996.
22. Kitamuro T, Takahashi K, Ogawa K, Udono RF, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, and Shibahara S. Bach 1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 14: 9125-9133, 2003.
23. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, and Dyck JR. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278: 39422-39427, 2003.
24. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, and Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14: S250-S253, 2003.
25. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, and Abraham N.G. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing and improves vascular reactivity in rat model of diabetes. Circulation 23: 3126-3134, 2005.
26. Kruger AL, Peterson SJ, Schwartzman ML, Fusco H, McClung JA, Weiss M, Shenouda S, Goodman AI, Goligorsky MS, Kappas A, and Abraham NG. Upregulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and anti-apoptotic effects. J Pharmacol Exp Ther 319: 1144-1152, 2006.
27. Laniado-Schwartzman M, Conners MS, Dunn MW, Levere RD, Kappas A, and Abraham NG. Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol 53: 1069-1075, 1997.
28. Li P, Jiang H, Yang L, Quan S, Dinocca S, Rodriguez F, Abraham NG, and Nasjletti A. Angiotensin II induces carbon monoxide production in the perfused kidney: relation to protein kinase C activation. Am J Physiol Renal Physiol 287: F914-F920, 2004.
29. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, Hakem R, Ohashi PS, and Woo M. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 25: 3620-3629, 2005.
30. Liao F, Li Y, O'Connor W, Zanetta L, Bassi R, Santiago A, Overholser J, Hooper A, Mignatti P, Dejana E, Hicklin DJ, and Bohlen P. Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res 60: 6805-6810, 2000.
31. Lorenzi M, Nordberg JA, and Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 36: 1261-1267, 1987.
32. Luo Y, Kwon HJ, Montano S, Georgiadis M, Goebl MG, and Harrington MA. Phosphorylation of Simpl modulates Rela associated NF-κB dependent transcription. Am J Physiol Cell Physiol 292: C1013-C1023, 2006.
33. McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG, and Kappas A. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 48: 345-350, 2005.
34. Meleth AD, Agron E, Chan CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL, III, and Chew EY. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46: 4295-4301, 2005.
35. Milstien S and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263: 681-684, 1999.
36. Nobe K, Miyatake M, Sone T, and Honda K. High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development. J Pharmacol Exp Ther 318: 530-539, 2006.
37. Okon EB, Chung AW, Rauniyar P, Padilla E, Tejerina T, McManus BM, Luo H, and van Breemen C. Compromised arterial function in human type 2 diabetic patients. Diabetes 54: 2415-2423, 2005.
38. Piconi L, Quagliaro L, Assaloni R, Da RR, Maier A, Zuodar G, and Ceriello A. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 22: 198-203, 2006.
39. Pieper GM, Meier DA, and Hager SR. Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. Am J Physiol 269: H845-H850, 1995.
40. Quan S, Kaminski PM, Yang L, Morita T, Inaba M, Ikehara S, Goodman AI, Wolin MS, and Abraham NG. Heme oxygenase-1 prevents superoxide anion associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 315: 509-516, 2004.
41. Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, and Srivastava SK. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53: 2910-2920, 2004.
42. Recchioni R, Marcheselli F, Moroni F, and Pieri C. Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L-cysteine. Metabolism 51: 1384-1388, 2002.
43. Rodella L, Lamon B, Rezzani R, Colombrita C, Sangras B, Scapagnini G, Falck JR, and Abraham NG. Carbon monoxide and biliverdin prevent oxidant production and endothelial cell sloughing in rats with type I diabetes. Free Radic Biol Med 40: 2198-2205, 2006.
44. Ruan H, Hacohen N, Golub TR, Van PL, and Lodish HF. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 51: 1319-1336, 2002.
45. Sacerdoti D, Olszanecki R, Li VG, Colombrita C, Scapagnini G, and Abraham NG. Heme oxygenase overexpression attenuates glucose-mediated oxidative stress in quiescent cell phase: linking heme to hyperglycemia complications. Curr Neurovasc Res 2: 103-111, 2005.
46. Shahab A. Why does diabetes mellitus increase the risk of cardiovascular disease? Acta Med Indones 38: 33-41, 2006.
47. Song R, Mahidhara RS, Zhou Z, Hoffman RA, Seol DW, Flavell RA, Billiar TR, Otterbein LE, and Choi AM. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 172: 1220-1226, 2004.
48. Stehouwer CD, Lambert J, Donker AJ, and van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34: 55-68, 1997.
49. Stocker R and Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004.
50. Tracz MJ, Alam J, and Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 18: 414-420, 2007.
51. Tsui TY, Siu YT, Schlitt HJ, and Fan ST. Heme oxygenase-1-derived carbon monoxide stimulates adenosine triphosphate generation in human hepatocyte. Biochem Biophys Res Commun 336: 898-902, 2005.
52. Turkseven S, Drummond G, Rezzani R, Rodella L, Quan S, Ikehara S, and Abraham N.G. Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway. J Cell Biochem 100: 815-823, 2007.
53. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella L, Ikehara S, Wolin MS, and Abraham NG. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 289: H701-H707, 2005.
54. Utsumi K, Kawabe M, Hirama A, Ueda K, Kamada Y, Arii K, Komaba Y, Katsura K, Iino Y, and Katayama Y. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis. Clin Chim Acta 377: 198-200, 2007.
55. Vendrame F, Santangelo C, Misasi R, Dionisi S, Gizzi C, Realacci M, Grassetti D, Di MU, and Dotta F. Defective lymphocyte caspase-3 expression in type 1 diabetes mellitus. Eur J Endocrinol 152: 119-125, 2005.
56. Wagener FA, da Silva JL, Farley T, de Witte T, Kappas A, and Abraham NG. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 291: 416-423, 1999.
57. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, and Lee PJ. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278: 1248-1258, 2003.
58. Zou MH, Cohen R, and Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97, 2004.
59. Zou MH, Shi C, and Cohen RA. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H2 receptor-mediated apoptosis and adhesion molecular expression in cultured human aortic endothelial cells. Diabetes 51: 198-203, 2002.